Pharmacokinetics and the effect of probenecid on the renal excretion mechanism of diprophylline. 1992

M Nadai, and R Apichartpichean, and T Hasegawa, and T Nabeshima
Department of Hospital Pharmacy, Nagoya University School of Medicine, Japan.

The mechanism of renal excretion of diprophylline (DPP) and the effect of probenecid on the active transport of DPP in renal tubules were investigated in rats. The concentration of DPP in plasma increased in proportion to the doses of 10, 30, and 60 mg/kg. The pharmacokinetic parameters and the urinary excretion of DPP did not change significantly with the dose. These findings indicate that DPP possesses dose-independent pharmacokinetics. Pharmacokinetic parameters for tubular secretion of DPP, as determined by a single-injection renal clearance method, were 21.25 micrograms/mL for the Michaelis-Menten constant and 102.38 micrograms/min for maximum velocity. Coadministration of probenecid decreased the total body clearance of DPP but did not change in the steady-state volume of distribution of DPP. The effect of probenecid concentration on the steady-state renal clearance of DPP was evaluated by continuously infusing probenecid at various rates. The renal clearance of DPP decreased as the probenecid concentration increased, a result indicating that probenecid inhibits the tubular secretion of DPP. However, probenecid did not inhibit the renal secretion of DPP completely, probably because of the existence of probenecid-insensitive transport systems for DPP in the renal proximal tubule. The Michaelis-Menten constant, maximum velocity, and glomerular filtration rate, as calculated with the competitive inhibition model for renal clearance of DPP, correlated well with estimated values after a single intravenous administration, as described earlier. The competitive inhibition constant of probenecid was 15.86 micrograms/mL.

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D008297 Male Males
D011339 Probenecid The prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate. Probenecid has also been used to treat patients with renal impairment, and, because it reduces the renal tubular excretion of other drugs, has been used as an adjunct to antibacterial therapy. Benecid,Benemid,Benuryl,Pro-Cid,Probecid,Probenecid Weimer
D004400 Dyphylline A THEOPHYLLINE derivative with broncho- and vasodilator properties. It is used in the treatment of asthma, cardiac dyspnea, and bronchitis. Dihydroxypropyltheophylline,Diprophylline,Dilin,Diphylline,Dylix,Lufyllin,Neothylline
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D017208 Rats, Wistar A strain of albino rat developed at the Wistar Institute that has spread widely at other institutions. This has markedly diluted the original strain. Wistar Rat,Rat, Wistar,Wistar Rats
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

M Nadai, and R Apichartpichean, and T Hasegawa, and T Nabeshima
January 1973, Acta pathologica et microbiologica Scandinavica. Section B: Microbiology and immunology,
M Nadai, and R Apichartpichean, and T Hasegawa, and T Nabeshima
January 1988, British journal of clinical pharmacology,
M Nadai, and R Apichartpichean, and T Hasegawa, and T Nabeshima
January 1997, British journal of clinical pharmacology,
M Nadai, and R Apichartpichean, and T Hasegawa, and T Nabeshima
July 1998, Research communications in molecular pathology and pharmacology,
M Nadai, and R Apichartpichean, and T Hasegawa, and T Nabeshima
January 1999, Antimicrobial agents and chemotherapy,
M Nadai, and R Apichartpichean, and T Hasegawa, and T Nabeshima
January 1986, American journal of veterinary research,
M Nadai, and R Apichartpichean, and T Hasegawa, and T Nabeshima
March 1955, Journal of applied physiology,
M Nadai, and R Apichartpichean, and T Hasegawa, and T Nabeshima
June 1983, Drug intelligence & clinical pharmacy,
M Nadai, and R Apichartpichean, and T Hasegawa, and T Nabeshima
January 1982, Antimicrobial agents and chemotherapy,
M Nadai, and R Apichartpichean, and T Hasegawa, and T Nabeshima
August 1983, The Journal of antimicrobial chemotherapy,
Copied contents to your clipboard!